A novel platinum-based chemotherapeutic inducing immunogenic cell death

Oncoimmunology. 2020 Feb 15;9(1):1729022. doi: 10.1080/2162402X.2020.1729022. eCollection 2020.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents* / therapeutic use
  • Humans
  • Immunogenic Cell Death
  • Neoplasms* / drug therapy
  • Platinum / therapeutic use

Substances

  • Antineoplastic Agents
  • Platinum